| Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. | |
| | |
MedLine Citation:
|
PMID: 22883134 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Detectable levels of cardiac troponins are common in individuals with chronic kidney disease (CKD), even in the absence of symptomatic cardiovascular disease. Abnormal cardiac troponin values are associated with coronary artery disease and left ventricular hypertrophy (LVH) and predict poor clinical outcomes. Elevated levels of fibroblast growth factor 23 (FGF-23) contribute to LVH in CKD. We investigated the association of FGF-23 and hs-cTnI (high-sensitivity cardiac troponin I) and hs-cTnT (high-sensitivity cardiac troponin T) levels in CKD and examined the role of LVH in this association. STUDY DESIGN: Cross-sectional observational study. SETTING & PARTICIPANTS: 153 stable outpatients with non-dialysis-dependent CKD. PREDICTOR: The primary predictor was FGF-23 level. OUTCOMES: hs-cTnI, hs-cTnT. MEASUREMENTS: FGF-23, hs-cTnI, hs-cTnT; left ventricular mass index (LVMI) assessed by echocardiography; coronary artery calcification (CAC) measured by computed tomography. LVMI and CAC were evaluated as potential mediators of the effect of FGF-23 on hs-cTnI/T. RESULTS: Mean age was 64 ± 12 (SD) years, mean estimated glomerular filtration rate was 34 ± 11 mL/min/1.73 m(2), median FGF-23 level was 120 (25th-75th percentile, 79-223) reference unit (RU)/mL, median hs-cTnI level was 6.5 (25th-75th percentile, 3.5-14.5) pg/mL, and median hs-cTnT level was 16.8 (25th-75th percentile, 11.1-33.9) pg/mL. cTnI and cTnT concentrations were higher than the 99th percentile of a healthy population in 42% and 61% of patients, respectively. In unadjusted and multivariable-adjusted analyses, hs-cTnI/T levels were associated significantly with FGF-23 levels. Adjusting for LVMI, but not CAC, weakened the association of FGF-23 and hs-cTnI/T levels. LIMITATIONS: Vitamin D levels were not measured. The prevalence of coronary artery disease may have been underestimated because it was ascertained by self-report. CONCLUSIONS: Minimally elevated cTnI and cTnT levels, detectable by high-sensitivity assays, are associated with elevated FGF-23 levels in stable outpatients with CKD. FGF-23-associated LVH may contribute to detectable hs-cTnI/T levels observed in non-dialysis-dependent patients with CKD. |
| | |
Authors:
|
Kelsey Smith; Christopher deFilippi; Tamara Isakova; Orlando M Gutiérrez; Karen Laliberte; Stephen Seliger; Walter Kelley; Show-Hong Duh; Michael Hise; Robert Christenson; Myles Wolf; James Januzzi |
Related Documents
:
|
16581474 - Quantitative adenosine real-time myocardial contrast echocardiography for detection of ... 22161434 - Cardiac testing for coronary artery disease in potential kidney transplant recipients. 1948114 - Dipyridamole perfusion scintigraphy. 11823094 - Myocardial and microcirculatory kinetics of br14, a novel third-generation intravenous ... 15729524 - Cognitive deficits and changes in neurometabolites after a lacunar infarct. 8573974 - Developments in surgical techniques for coronary revascularization. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2012-08-09 |
Journal Detail:
|
Title: American journal of kidney diseases : the official journal of the National Kidney Foundation Volume: 61 ISSN: 1523-6838 ISO Abbreviation: Am. J. Kidney Dis. Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2012-12-18 Completed Date: 2013-02-21 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 8110075 Medline TA: Am J Kidney Dis Country: United States |
Other Details:
|
Languages: eng Pagination: 67-73 Citation Subset: IM |
Copyright Information:
|
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Biological Markers / blood Comorbidity Coronary Artery Disease / epidemiology Cross-Sectional Studies Echocardiography Female Fibroblast Growth Factors / blood* Glomerular Filtration Rate / physiology Humans Hypertrophy, Left Ventricular / blood*, epidemiology*, ultrasonography Male Middle Aged Multivariate Analysis Prevalence Prognosis Renal Insufficiency, Chronic / blood*, epidemiology*, physiopathology Sensitivity and Specificity Troponin I / blood* |
| Grant Support | |
ID/Acronym/Agency:
|
K23 DK087858/DK/NIDDK NIH HHS; K30RR02229207/RR/NCRR NIH HHS; M01RR01066/RR/NCRR NIH HHS; R01 DK076116/DK/NIDDK NIH HHS; R01DK076116/DK/NIDDK NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Troponin I; 0/fibroblast growth factor 23; 62031-54-3/Fibroblast Growth Factors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Exertional Fatigue in Patients With CKD.
Next Document: Associations between coronary calcification on chest radiographs and mortality in hemodialysis patie...